Skip to content
Antidiabetics

Metformin vs Empagliflozin

The table compares the compounds’ key data from their entry pages. Open each compound’s full entry for details. Educational content, not medical advice.

What it is
MetforminThe usual starting medicine for type 2 diabetes worldwide; prescription only, taken by mouth.
EmpagliflozinPrescription medicine for diabetes, heart failure and chronic kidney disease that removes excess sugar in the urine.
ATC code
MetforminA10BA02
EmpagliflozinA10BK03
Prescription
MetforminPrescription only (Rx)
EmpagliflozinPrescription only (Rx)
Mechanism
MetforminReduces glucose production in the liver via the cell's energy sensor
EmpagliflozinSGLT2 (sodium-glucose cotransporter 2) inhibitor, proximal renal tubule
Half-life
Metformin4-9 h (plasma), 17 h (erythrocyte)
Empagliflozin~12.4 h (once-daily dosing)
Onset
Metformin1-3 h (single dose), 4-7 days (steady-state HbA1c)
EmpagliflozinGlucosuria within first dose; HbA1c and blood pressure changes over several weeks

Metformin or empagliflozin: what is the difference?

Both are prescription medicines for type 2 diabetes, but they lower blood sugar in different ways. Metformin switches on the cell's energy-sensing enzyme, so the liver produces less new sugar and insulin sensitivity improves; empagliflozin blocks a transporter called SGLT2 in the kidney, so excess sugar leaves the body in the urine. Metformin is the usual starting treatment for type 2 diabetes worldwide and is also prescribed off-label in prediabetes and polycystic ovary syndrome; empagliflozin (Jardiance) is also used for heart failure and chronic kidney disease. The two are also sold together in a combination product (Synjardy).

Personalized consultation

Want a detailed conversation tailored to your data?

Fill out the prep intake form (your goals, training and health data), and the advisor prepares from it to give genuinely personalized guidance.

Fill out the form

~5–7 min · prep questionnaire · confidential · GDPR-compliant